טוען...
Prognostic significance of castrate testosterone levels for patients with intermediate and high risk prostate cancer
BACKGROUND: Testosterone level of < 50 ng/dL has been used to define castrate level after surgery or after androgen deprivation treatment (ADT) in metastatic prostate cancer (PC). AIM: To evaluate the effect of two different castrate testosterone levels, < 50 and < 20 ng/dL, on biochemical...
שמור ב:
| הוצא לאור ב: | World J Clin Oncol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Baishideng Publishing Group Inc
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6717705/ https://ncbi.nlm.nih.gov/pubmed/31528544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v10.i8.283 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|